Table 1. Baseline characteristics and admission data of the studdy population.
| Characteristics | AMI (n = 87) | CAD (n = 33) | Control (n = 39) | P value |
| General data | ||||
| Age (years) | 69±13 | 64±10 | 66±8 | 0.07 |
| Gender (female/male) | 20/67 | 9/24 | 9/30 | 0.88 |
| Body mass index (kg/m2) | 24.08±3.21 | 24.33±2.47 | 24.45±2.93 | 0.88 |
| Systolic blood pressure (mmHg) | 137.65±21.14 | 129.32±17.60 | 127.41±18.40 | 0.087 |
| Gensini | 067.53±37.24 | 045.93±29.17 | 02.57±1.67 | P < 0.001 |
| Cardiovascular risk factors [n(%)] | ||||
| Hypercholesterolemia | 09 (10.3%) | 03 (9.09%) | 02 (5.13%) | 0.634 |
| Hypertension | 70 (80.5%) | 29 (87.9%) | 33 (84.6%) | 0.600 |
| Laboratory parameters | ||||
| CK-MB (U/L) | 048.71±89.64 | 12.09±8.74 | 10.45±2.43 | *0.010* |
| Troponin T (µg/L) | 00.35±0.53 | 00.05±0.00 | 00.05±0.01 | *0.000* |
| Triglycerides (mmol/L) | 01.81±1.20 | 01.96±1.29 | 01.52±0.71 | 0.333 |
| Medication [n(%)] | ||||
| Beta-blocker | 21 (24.1%) | 05 (15.2%) | 3 (7.7%) | 0.077 |
| Calcium channel blockers | 25 (28.7%) | 11 (33.3%) | 05 (12.8%) | 0.092 |
| Diuretics | 4 (4.6%) | 0 (-)000 | 1 (2.6%) | 0.426 |
| Statin | 19 (21.8%) | 05 (15.2%) | 3 (7.7%) | 0.142 |
| ACEI or ARB | 46 (52.9%) | 13 (39.4%) | 19 (48.7%) | 0.421 |
| Medical history [n(%)] | ||||
| stroke | 4 (4.6%) | 1 (3.0%) | 0 (-) | 0.395 |
| PCI | 8 (9.2%) | 1 (3.0%) | 0 (-) | 0.092 |
AMI: acute myocardial infarction; CAD: coronary artery disease; CK-MB: creatine kinase MB fraction; ACEI: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blockers; PCI: percutaneous coronary intervention. The body-mass index is the weight in kilograms divided by the square of the height in meters. Data are presented as number (percentage) or as mean±SD. *P < 0.05.